Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab – a single centre cohort study. Swiss Medical Weekly, [S. l.], v. 151, n. 3132, p. w20550, 2021. DOI: 10.4414/smw.2021.20550. Disponível em: https://smw.ch/index.php/smw/article/view/3045. Acesso em: 25 oct. 2025.